Daly, C. and Briddon, S. (2022) Pharmacology in the Metaverse. Pharmacology Matters, 2022(August),
Full text not currently available from Enlighten.
Publisher's URL: https://www.bps.ac.uk/publishing/pharmacology-matters/august-2022/pharmacology-in-the-metaverse
Abstract
The recent rebranding of Facebook to Meta signalled the company’s focus on investment in the Metaverse (or Omniverse if you are following NVIDIA’s developments). Whatever the name, the ‘verse had a global market size of $38.8bn in 2021 and is expected to grow to $678bn by 2030. Is this the beginning of something big, and should pharmacologists already be looking to embrace it early in its development phase? In this article, we will explore what the pharmacology of the future might look like in the Metaverse and how it could change our teaching and research.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Daly, Professor Craig |
| Authors: | Daly, C., and Briddon, S. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Pharmacology Matters |
| Publisher: | British Pharmacological Society |
| ISSN: | 1757-8175 |
| ISSN (Online): | 1757-8183 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details